Search references for MSP 1014. Phrases containing MSP 1014
See searches and references containing MSP 1014!MSP 1014
Psychedelic drug
MSP-1014 is a serotonergic psychedelic which is under development for the treatment of major depressive disorder, other depressive disorders, and anxiety
MSP-1014
Pharmaceutical compound
hallucinogens and entactogens Lucigenol MSP-1014 "MSP 2020". AdisInsight. 14 January 2026. Retrieved 15 January 2026. MSP 2020 is an oral pyrrolidine-indole
MSP-2020
South American psychoactive decoction
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Ayahuasca
Monoamine neurotransmitter
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Serotonin
Species of psychoactive cactus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Peyote
Mushrooms containing psychoactive indole alkaloids
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psilocybin_mushroom
Psychedelic drug
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Dimethyltryptamine
Species of fungus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psilocybe_cubensis
Psychoactive drug, often called ecstasy
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
MDMA
Species of plant
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Mimosa_tenuiflora
Fungi of the genus Claviceps
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Ergot
Naturally occurring psychedelic compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Mescaline
Chemical compound
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
9-Methyl-β-carboline
Psychedelic drug
prodrugs of psilocin and have similar properties and effects. More recently, MSP-1014 has emerged as a novel prodrug of psilocin under development for the treatment
Psilocin
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
4-PrO-MET
serotonin reuptake inhibitor – post-traumatic stress disorder – Tactogen MSP-1014 (psilocin prodrug) – non-selective serotonin receptor agonist and psychedelic
List of investigational hallucinogens and entactogens
List_of_investigational_hallucinogens_and_entactogens
Hallucinogenic mushroom preparation
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Magic_truffle
Species of fungus in the family Hymenogastraceae, native to Europe
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psilocybe_semilanceata
Perennial flowering plant in the coffee family Rubiaceae
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psychotria_viridis
Common name for more than 1,000 species of flowering plants in the family Convolvulaceae
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Morning_glory
Genus of plants
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Acacia
Serotonin receptor agonist
1-Methylpsilocin (CMY-16) 4-HO-5-MeO-T 5-Methoxypsilocybin CT-4201 EB-002 (EB-373) MSP-1014 O-4310 Psilomethoxin Many or all of these compounds are serotonin receptor
4-Hydroxytryptamine
Pharma (acquired by Otsuka Pharmaceutical) – MSP-1014 (psilocin prodrug), MSP-2020, MSP-4018, MSP-4019, MSP-4020 Mindstate Design Labs – 5-MeO-MiPT (MSD-001)
List of psychedelic pharmaceutical companies
List_of_psychedelic_pharmaceutical_companies
Psychedelic drug
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
2C-B
N-DEAOP-NMT, 5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
List_of_psychedelic_drugs
Species of cactus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Pachycereus_pringlei
Food containing hallucinogenic substances
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Mushroom_edible
Species of fungus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psilocybe_cyanescens
Retail outlet selling hallucinogenic mushroom products
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psychedelic_mushroom_store
Genus of plants
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Virola
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
N-DEAOP-NMT
Psychedelic drug found in toads, mushrooms and plants
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Bufotenin
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Tabernanthalog
Class of chemical compounds
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Scaline
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
JRT_(drug)
Form of psychoactive drugs
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Hallucinogenic_snuff
DMT-infused smoking blend
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Changa_(drug)
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
2C-G-5
Index of plants with the same common name
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
San_Pedro_cactus
Chemical compound found in some species of mushrooms
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psilocybin
Hallucinogenic class of psychoactive drug
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psychedelic_drug
Drugs that promote rapid and sustained neuroplasticity
Substituted tryptamines: psilocin, psilocybin, 4-AcO-DMT, deupsilocin, MSP-1014, DMT, bretisilocin, deudimethyltryptamine, 5-MeO-DMT, 4-HO-DiPT, luvesilocin
Psychoplastogen
Chemical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
4-HO-MET
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
VCU-1012
Index of chemical compounds with the same name
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Dimethoxyamphetamine
Class of chemical compounds
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
FLY_(psychedelics)
Chemical compound, Novel psychoactive substance analog, LSD prodrug
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
1S-LSD
Serotonergic psychedelic
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Ibogainalog
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
6-Hydroxy-DET
Serotonergic psychedelic
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Deupsilocin
Serotonergic psychedelic
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Deudimethyltryptamine
Cactus containing psychoactive chemicals
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psychoactive_cactus
Psychedelic drug
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
LSD
Index of chemical compounds with the same name
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Trimethoxyamphetamine
Species of fungus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psilocybe_mexicana
Drug belonging to the tryptamine class
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
4-Methyl-α-methyltryptamine
Psychoactive substance that induces spiritual experiences
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Entheogen
Species of plant
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Acacia_confusa
Psychoactive drug
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Α,N,N-Trimethyltryptamine
Species of cactus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Echinopsis_macrogona
Psychedelic drug
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
5-Bromo-DMT
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
SPL028
Species of fungus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psilocybe_azurescens
Chemical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
1V-LSD
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
1D-LSD
Chemical compound
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
Giredestrant
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
4-Thioescaline
Species of cactus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Echinopsis_lageniformis
Psychoactive drug taken by mouth
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
(R)-MDMA
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
1Fe-LSD
Chemical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Methylethyltryptamine
Psychedelic drug
4-PrO-DMT, and psilocybin include CT-4201, EB-002, RE-109 (4-GO-DMT), and MSP-1014. 4-AcO-DMT and several other esters of psilocin were patented on January
4-AcO-DMT
Group of chemical compounds
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
Β-Carboline
Chemical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Psilomethoxin
Designer drug combination mimicking MDMA
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Borax_combo
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
NBoc-DMT
Chemical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
4-PrO-DMT
Chemical compound
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
Dimethyltryptamine-N-oxide
Class of chemical compounds
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Partial_lysergamide
Chemical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
1cP-LSD
Book about phenethylamines
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
The_Shulgin_Index
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
CT-5172
Pharmaceutical compound
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
Deuterated_mitragynine
Serotonergic psychedelic
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
HLP005
Species of fungus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Claviceps_paspali
Chemical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
NDTDI
Chemical compound
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
Zalsupindole
Class of chemical compounds
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
Pyridopyrroloquinoxaline
Medication used for migraines & cluster headaches
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
Sumatriptan
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
3,4-Dimethoxyphenethylamine
Brand of mushroom edibles
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Diamond_Shruumz
Species of plant
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Diplopterys_cabrerana
1997 book by Alexander Shulgin and Ann Shulgin
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
TiHKAL
Drug class
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Serotonin 5-HT2A receptor agonist
Serotonin_5-HT2A_receptor_agonist
Species of amphibian
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Colorado_River_toad
Psychedelic drug
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
5-MeO-DMT
Chemical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
N-Methyltryptamine
Species of fungus
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
Periglandula_ipomoeae
Opioid analgesic compound
(EB-373) Ethocybin (4-PO-DET; CEY-19) Luvesilocin (4-GO-DiPT; RE-104; FT-104) MSP-1014 Norbaeocystin (4-PO-T) Norpsilocin (4-HO-NMT) O-4310 (1-iPrO-6-F-psilocin)
Mitragynine
Pharmaceutical compound
5-MeO-N-DEAOP-NMT, 5-MeO-N-DEAOP-NET) Structure undisclosed: CT-4201 EB-002 (EB-373) MSP-1014 MYCO-004 Cyclized Ergolines/lysergamides (e.g., LSD) Ibogalogs (e.g., ibogainalog
2C-G
MSP 1014
MSP 1014
MSP 1014
MSP 1014
MSP 1014
MSP 1014
MSP 1014
MSP 1014
MSP 1014